Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Armando Sánchez-Quijano"'
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 24:518-526
Hepatitis C virus infection is the principal cause of chronic liver disease, cirrhosis and hepatocellular carcinoma in the Western World. Chronic hepatitis C is often silent, most of the times discovered only by routine serologic or biochemical testi
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 24:453-462
Nuestro conocimiento acerca de la historia natural de la infeccion cronica por el virus de la hepatitis B (VHB) ha progresado de manera muy importante en los ultimos 25 anos. La infeccion se entiende ahora como la sucesion de 3 fases: inmunotoleranci
Autor:
Ezequiel Ruiz-Mateos, Alejandro Vallejo, Natalia Soriano-Sarabia, Manuel Leal, Eduardo Lissen, Sonia Molina-Pinelo, Armando Sánchez-Quijano, Carmen Delgado, Beatriz de Felipe
Publikováno v:
Journal of Clinical Immunology. 25:296-302
Whether HAART allows complete recovery of humoral immune function in HIV-infected individuals is still controversial. Our objective was to study the effect of HAART on both B cell repopulation and hypergammaglobulinemia in 72 naïve patients, includi
Autor:
R. de la Rosa, Amalia Rubio, Armando Sánchez-Quijano, A. Vallejo, Miguel C. Leal, Eduardo Lissen, Ezequiel Ruiz-Mateos
Publikováno v:
Clinical and Experimental Immunology. 136:501-506
SUMMARYAge is one of the main factors involved in the rapidity and the magnitude of CD4+ T cell repopulation in human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART). Improved thymic function has been
Autor:
Rafael de la Rosa, Amalia Rubio, Manuel Leal, Natalia Soriano, Jaime M. Franco, Armando Sánchez-Quijano, Ezequiel Ruiz-Mateos, Eduardo Lissen, Manuel Martinez-Moya
Publikováno v:
AIDS. 17:947-954
Objective Immune reconstitution after highly active antiretroviral therapy (HAART) in HIV-infected patients has led to an increase in the number of new CD4 T lymphocytes. Neolymphopoiesis in the thymus has been proposed as a mechanism in T-cell regen
Autor:
Manuel Martinez-Moya, Eduardo Lissen, Amalia Rubio, Elena Merchante, Armando Sánchez-Quijano, Jaime M. Franco, Manuel Leal
Publikováno v:
Blood. 99:3702-3706
The origin of T cells after highly active antiretroviral therapy (HAART) in patients infected with human immunodeficiency virus 1 (HIV-1) is now under discussion. The possibility of renewed lymphopoiesis in aged thymuses is still controversial. In th
Autor:
Juan Macías, Antonio Núñez-Roldán, Miguel C. Leal, B. Sánchez, Eduardo Lissen, C. Rey, Amalia Rubio, Armando Sánchez-Quijano, Juan A. Pineda, Jaime M. Franco
Publikováno v:
Scopus-Elsevier
The aim of this work was to analyze the effects of highly active antiretroviral therapy on the chronically activated immune system of 26 antiretroviral-naive HIV-1-infected patients. Samples from baseline to week 24 or 36 of treatment were tested for
Autor:
Francisco J. Medrano, Enrique J. Calderón, Y. Torres, Eduardo Lissen, Manuel Leal, Armando Sánchez-Quijano, C. Rey
Publikováno v:
European Journal of Clinical Investigation. 28:930-936
BackgroundThe objective of the present study was to investigate the relationship between the serum cytokine pattern of T-helper (Th) response and the acquisition of syncytium-inducing (SI) human immunodeficiency virus type 1 (HIV-1) variants in HIV-1
Autor:
Y. Torres, Manuel Leal, Arianna Zagliani, Donatella Arienti, C. Rey, Mario Clerici, Eduardo Lissen, Francisco J. Medrano, Armando Sánchez-Quijano
Publikováno v:
AIDS Research and Human Retroviruses. 14:835-843
The relationship between serum concentration of different components of the nerve growth factor/tumor necrosis factor (TNF) receptor family, including soluble APO-1/Fas (sAPO-1/Fas) and progression of HIV infection, was analyzed in a case-control stu
Autor:
Antonio Caruz, Francisco J. Medrano, C. Rey, Manuel Leal, Y. Torres, Eduardo Lissen, Armando Sánchez-Quijano
Publikováno v:
CIÊNCIAVITAE
Scopus-Elsevier
Scopus-Elsevier
The objective of the present study was to investigate the effect of the nucleoside analogue treatment on serum viraemia, CD4+ cell count and disease progression in patients with and without syncytium-inducing (SI) HIV-I variants. To achieve this in a